Maine Revised Statutes
Subchapter 9: MISCELLANEOUS PROVISIONS
32 §13786-F. Dispensing of emergency supplies of chronic maintenance drug

§13786-F. Dispensing of emergency supplies of chronic maintenance drug
1.  Definition.  For the purposes of this section, "chronic maintenance drug" means a medication prescribed to treat a chronic, long-term condition and that is taken on a regular, recurring basis.  
[PL 2021, c. 566, §2 (NEW).]
2.  Emergency supply.  A pharmacist may dispense an emergency supply of a chronic maintenance drug without a current, valid prescription from a practitioner, subject to the following requirements:  
A. The pharmacy at which the pharmacist is practicing has a record of a prescription for the chronic maintenance drug in the name of the patient who is requesting the emergency supply, including the amount of the chronic maintenance drug dispensed as provided in the most recent prescription or the standard unit of dispensing for the chronic maintenance drug, and the record of that prescription for the chronic maintenance drug does not include a notation from a practitioner that no emergency supply is permitted;   [PL 2021, c. 566, §2 (NEW).]
B. The pharmacist attempts but is unable to obtain authorization to refill the prescription described in paragraph A from the practitioner who issued the prescription or another practitioner responsible for the patient's care;   [PL 2021, c. 566, §2 (NEW).]
C. In the pharmacist's professional judgment, the chronic maintenance drug is essential to sustain the life of the patient or to continue therapy for a chronic condition of the patient and failure to dispense the chronic maintenance drug could reasonably produce undesirable health consequences or cause physical or mental discomfort;   [PL 2021, c. 566, §2 (NEW).]
D. Except as provided in this subsection, the amount of the chronic maintenance drug dispensed does not exceed a 30-day supply as provided in the prescription or, if the standard unit of dispensing for the chronic maintenance drug exceeds a 30-day supply, the amount of the chronic maintenance drug dispensed does not exceed the smallest standard unit of dispensing;   [PL 2021, c. 566, §2 (NEW).]
E. With respect to a chronic maintenance drug that is a controlled substance included in Schedule III or IV of 21 United States Code, Section 812 or 21 Code of Federal Regulations, Section 1308, the amount of the chronic maintenance drug dispensed does not exceed a 7-day supply;   [PL 2021, c. 566, §2 (NEW).]
F. The chronic maintenance drug is not a controlled substance included in Schedule I or II of 21 United States Code, Section 812 or 21 Code of Federal Regulations, Section 1308; and   [PL 2021, c. 566, §2 (NEW).]
G. The pharmacist has not dispensed the chronic maintenance drug in an emergency supply under this subsection to the same patient more than twice in the preceding 12-month period.   [PL 2021, c. 566, §2 (NEW).]
The pharmacist shall exercise professional judgment in determining the amount of the chronic maintenance drug to be dispensed, up to the maximum amount specified in this subsection. The pharmacist shall notify the practitioner who issued the prescription or another practitioner responsible for the patient's care no later than 72 hours after the chronic maintenance drug is dispensed. The pharmacist shall fulfill all documentation and other requirements established by the board when dispensing an emergency supply of a chronic maintenance drug.  
[PL 2021, c. 566, §2 (NEW).]
3.  Rules.  The board may adopt rules for determining what constitutes a chronic maintenance drug and what reporting procedures are necessary in dispensing an emergency supply of a chronic maintenance drug. Rules adopted by the board pursuant to this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A.  
[PL 2021, c. 566, §2 (NEW).]
SECTION HISTORY
PL 2021, c. 566, §2 (NEW).

Structure Maine Revised Statutes

Maine Revised Statutes

TITLE 32: PROFESSIONS AND OCCUPATIONS

Chapter 117: MAINE PHARMACY ACT

Subchapter 9: MISCELLANEOUS PROVISIONS

32 §13781. Generic and therapeutically equivalent substitution

32 §13782. Advertising

32 §13782-A. Price disclosure

32 §13783. Posting prices (REPEALED)

32 §13784. Patient information regulation

32 §13785. Patient profile record system regulation

32 §13786. Identification of persons prescribing medicines on hospital prescription blanks

32 §13786-A. Security requirements; rules

32 §13786-B. Partial dispensing of prescription for opioid medication

32 §13786-C. Dispensing of prescription of opioid medication; immunity

32 §13786-D. Prescribing and dispensing insulin

32 §13786-E. Prescribing, dispensing and administering HIV prevention drugs

32 §13786-F. Dispensing of emergency supplies of chronic maintenance drug

32 §13787. Hypodermic syringes; prescriptions (REPEALED)

32 §13787-A. Sale of hypodermic apparatus

32 §13788. Sale of poisonous drugs

32 §13789. Possession of drug samples

32 §13790. Using drugs not in prescription

32 §13791. Return of drugs

32 §13792. Sale by certain methods prohibited

32 §13793. Adulterating and selling drugs

32 §13794. Labeling of prescriptions

32 §13795. Photographic proof of identification; discretion to sell or dispense; immunity

32 §13796. Retail sale of targeted methamphetamine precursors

32 §13797. Prescription drug price information

32 §13798. Expedited partner therapy

32 §13799. Consumer choice preserved

32 §13800. Access to distributed drugs

32 §13800-A. Liability for product of another; exemption

32 §13800-B. Prohibition on providing conversion therapy to minors

32 §13800-C. Opioid medication product registration fee

32 §13800-D. Insulin product registration fee (WHOLE SECTION TEXT EFFECTIVE UNTIL 1/01/27) (WHOLE SECTION TEXT REPEALED 1/01/27)